References
- Avdeef A. pH-metric log P. 2. Refinement of partition coefficients and ionization constants of multiprotic substances. Journal of Pharmaceutical Sciences 1993; 82: 183–190
- Guengerich F. P., MacDonald T. L. Chemical mechanisms of catalysis by cytochrome P-450: a unified view. Accounts of Chemical Research 1984; 17: 9–16
- Gwilt M., Arrowsmith J. E., Blackburn K. J., Burges R. A., Cross P. E., Dalrymple H. W., Higgins A. J. UK-68, 798: a novel, potent and highly selective class III agent which blocks potassium channels in cardiac cells. Journal of Pharmacology and Experimental Therapeutics 1991; 265: 318–324
- Ishizaki T., Tawara K. Relationship between pharmacokinetics and pharmacodynamics of the beta adrenergic blocking drug sotalol in dogs. Journal of Pharmacology and Experimental Therapeutics 1979; 211: 331–337
- Lowry O. H., Rosebrough N. M., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
- Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370–2378
- Remmer H., Schenkman J. B., Estabrook R. W., Sasame H., Gillette J. R., Narasimhulu S., Cooper D. Y., Rosenthal O. Drug interactions with hepatic microsomal cytochrome. Molecular Pharmacology 1966; 2: 187–190
- Rodrigues A. D. Use of in vitro human metabolism studies in drug development. An industrial perspective. Biochemical Pharmacology 1994; 48: 2147–2156
- Smith D. A., Jones B. C., Walker D. K. Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics. Medicinal Research Reviews 1996; 16: 243–266
- Smith D. A., Rasmussen H. S., Stopher D. A., Walker D. K. Pharmacokinetics and metabolism of dofetilide in mouse, rat, dog and man. Xenobiotica 1992; 22: 709–719
- Stopher D. A., McClean S. An improved method for the determination of distribution coefficients. Journal of Pharmacy and Pharmacology 1990; 42: 144
- Walker D K., Smith D. A., Stopher D. A. Liquid-liquid extraction and high performance chromatography for the determination of a novel antidysrhythmic agent (UK-68, 798) in human urine. Journal of Chromatography 1991; 568: 475–480
- Walker D. K., Alabaster C. T., Congrave G. S., Hargreaves M. B., Hyland R., Jones B. C., Reed L. J., Smith D. A. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide: in vitro studies and correlation with in vivo data. Drug Metabolism and Disposition 1996; 24: 447–455
- Wilkinson G. R. Plasma and tissue binding considerations in drug disposition. Drug Metabolism Reviews 1983; 14: 427–465
- Young R. C., Mitchell R. C., Brown T. H., Ganellin C. R., Griffiths R., Jones M., Rana K. K., Saunders D., Smith I. R., Sore N. E., Wilks T. J. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. Journal of Medicinal Chemistry 1988; 31: 656–671